治疗库辛病的新趋势
Odysseas Violetis1, Krystallenia I Alexandraki1
12nd Department of Surgery, Aretaieio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
TouchREVIEWS in endocrinology
|November 11, 2024
概括
库辛病通常在手术后复发. 针对激素分泌和瘤生长的新疗法,包括垂体和上腺治疗,为患者提供了改进的治疗选择.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子医学是分子医学.
背景情况:
- 手术后高复发率的库辛病需要新的治疗策略.
- 最近对库辛病病理生理学的分子洞察力揭示了新的治疗点.
研究的目的:
- 审查库辛病管理的新兴治疗目标.
- 讨论新的药理学药剂和治疗方法.
主要方法:
- 关于库辛病研究近期进展的文献综述.
- 分子见解和病理生理学理解的分析.
- 针对激素分泌和瘤增殖的研究和批准药物的概述.
主要成果:
- 帕西雷奥提德是一种体静止素受体连接体,已被批准用于垂体治疗.
- 研究性药物向细胞周期,信号和表观遗传学.
- 新的类固醇抑制剂 (莱沃克托可纳,奥西洛德罗斯塔特) 和米费普里斯替代品 (复合剂) 正在出现.
- 上腺ACTH受体阻塞和免疫治疗是潜在的未来策略.
结论:
- 了解库辛病的进展正在推动针对性治疗的发展.
- 一系列新的治疗方法,从垂体到上腺作用剂,正在改善管理选择.
- 未来的治疗方法可能包括免疫疗法和受体阻断,以改善患者的治疗结果.
相关概念视频
01:27Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:29Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
01:15Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236